SANOFI 82.580 € (-0,35 %)
ID LOGISTICS GROUP 325.500 € (-2,54 %)
EVERGREEN 0.170 € (+129,05 %)
VALEO 10.400 € (-4,98 %)
ADYEN 845.200 € (-2,14 %)
ING GROEP N.V. 22.945 € (-1,25 %)
WOLTERS KLUWER 65.320 € (+0,37 %)
KERING 265.250 € (+0,78 %)
KPN KON 4.848 € (+1,66 %)
STELLANTIS NV 6.574 € (+3,97 %)
Vusion 108.700 € (-2,16 %)
ALLFUNDS GROUP 8.600 € (+0,58 %)
THEON INTERNAT 34.000 € (+1,49 %)
ROBERTET 815.000 € (+0,25 %)
ASML HOLDING 1 161.000 € (-2,24 %)
NSE 49.500 € (-0,80 %)
TOUAX 3.940 € (0,00 %)
BNP PARIBAS ACT.A 83.300 € (-2,44 %)
FORVIA 9.944 € (-2,27 %)
KALRAY 3.405 € (-2,71 %)
POXEL 0.281 € (-11,91 %)
EXAIL TECHNOLOGIES 133.000 € (+1,53 %)
RUBIS 35.060 € (+0,57 %)
ORANGE 17.890 € (+1,22 %)
ASR NEDERLAND 60.920 € (+0,33 %)
AIRBUS 165.140 € (-1,64 %)
BOIRON 28.000 € (+1,08 %)
PLANISWARE 14.580 € (-0,82 %)
ARCELORMITTAL SA 45.660 € (-2,14 %)
PHILIPS KON 23.580 € (-0,08 %)
NOVACYT 0.373 € (-1,84 %)
ENGIE 28.970 € (+2,01 %)
STMICROELECTRONICS 29.085 € (-2,84 %)
BE SEMICONDUCTOR 190.150 € (+1,39 %)
WORLDLINE 0.289 € (+6,10 %)
DSM FIRMENICH AG 61.420 € (+1,12 %)
EIFFAGE 135.700 € (-0,33 %)
HEINEKEN HOLDING 62.850 € (+0,24 %)
2CRSI 28.700 € (-2,21 %)
SCHNEIDER ELECTRIC 236.150 € (-1,58 %)
FNAC DARTY 35.250 € (0,00 %)
SHELL PLC 40.605 € (+2,73 %)
LATECOERE 0.021 € (+5,05 %)
ALUMEXX N.V. 1.440 € (-1,37 %)
VINCI 131.600 € (-0,75 %)
NANOBIOTIX 27.400 € (-5,35 %)
PROSUS 40.020 € (-1,26 %)
FRANCAISE ENERGIE 41.050 € (+7,74 %)
INPOST 15.130 € (+0,07 %)
SAFRAN 287.300 € (-1,14 %)
AALBERTS NV 30.020 € (-2,09 %)
NEOVACS 0.001 € (-16,67 %)
ALPES (COMPAGNIE) 24.700 € (+1,23 %)
EURONEXT 143.300 € (+2,07 %)
MAUREL ET PROM 10.920 € (+7,48 %)
AHOLD DEL 41.730 € (+1,29 %)
ALTAMIR 24.600 € (0,00 %)
LHYFE 2.490 € (-0,20 %)
TOTALENERGIES 79.420 € (+2,40 %)
ABC ARBITRAGE 5.300 € (-0,93 %) |
24/03/2026 16:50
LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior BondsEQS-News: LR Health & Beauty SE / Key word(s): Bond LR Health & Beauty SE announces successful conclusion of the Written Procedure initiated on 6 March 2026 under the 2024/2028 Bonds and issuance of Super Senior Bonds Ahlen, 24 March 2026 – On 6 March 2026, LR Health & Beauty SE (the “Company”) initiated a written procedure (the “Written Procedure”) under the terms and conditions for the Company’s 2024/2028 bonds (ISIN: NO0013149658) (the “Bonds”) to implement certain amendments to, and request certain temporary waivers under, the terms and conditions for the Bonds in order to inter alia enable the incurrence of a super senior bridge financing in the form of a new bond in the amount of EUR 10,000,000 which will rank super senior in relation to the Bonds (the “Super Senior Bond”). Deadline for voting in the Written Procedure was 15:00 hrs CET today. Votes representing a sufficient part of the adjusted nominal amount of the Bonds were obtained in order to form a quorum and a requisite majority of the adjusted nominal amount voted in favour of the amendments and the temporary waivers in the Written Procedure. Consequently, the amendments and the temporary waivers are effective immediately and the Company will issue the Super Senior Bond on or about 26 March 2026. Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence. The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe. In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report. PR Contact: LR Health & Beauty SE cometis AG 24.03.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
2297090 24.03.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière